Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,000)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04973007 | Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases | terminated | Phase 4 | 10 | University of Colorado, DenverOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06077487 | Ketamine-assisted Therapy for Advanced GI Cancer | terminated | Phase 4 | 1 | Brian Anderson, MDOTHER | 1 | May 21, 2025 | clinicaltrials |
| Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy |
| terminated |
| Phase 4 |
| 2 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Dec 31, 2024 |
| clinicaltrials |
| NCT05354856 | The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. | terminated | Phase 4 | 11 | Rigshospitalet, DenmarkOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT01468623 | Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6(PROFUSE) | terminated | Phase 4 | 51 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jul 19, 2023 | clinicaltrials |
| NCT04155008 | Nutrition and Pharmacological Algorithm for Oncology Patients Study | terminated | Phase 4 | 1 | Montefiore Medical CenterOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT01760616 | Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy | terminated | Phase 4 | 790 | Qidong Gaitianli Medicines Co., LtdINDUSTRY | 1 | Mar 6, 2020 | clinicaltrials |
| NCT01806740 | DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC(DCE-MRI) | terminated | Phase 4 | 37 | GuerbetINDUSTRY | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01600196 | Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus | terminated | Phase 4 | 126 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT01740947 | Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?(SELECT) | terminated | Phase 4 | 485 | H. Jaap Bonjer, PhDOTHER | 1 | Nov 9, 2018 | clinicaltrials |
| NCT01768988 | Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study(PANPAIN/1) | terminated | Phase 4 | 20 | Parc de Salut MarOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT01849588 | HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) | terminated | Phase 4 | 3 | Massachusetts General HospitalOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT01260194 | A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer | terminated | Phase 4 | 4 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00642733 | A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer | terminated | Phase 4 | 6 | Hoffmann-La RocheINDUSTRY | 1 | Aug 24, 2016 | clinicaltrials |
| NCT01706822 | Radial Reload Laparoscopic LAR Case Series | terminated | Phase 4 | 8 | Medtronic - MITGINDUSTRY | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00129870 | CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer | terminated | Phase 4 | 180 | SanofiINDUSTRY | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00327093 | Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases | terminated | Phase 4 | 31 | Hospices Civils de LyonOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00216424 | Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma | terminated | Phase 4 | 40 | James A. Haley Veterans Administration HospitalFED | 1 | Nov 12, 2007 | clinicaltrials |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer | terminated | Phase 4 | 800 | Genentech, Inc.INDUSTRY | 0 | May 29, 2006 | clinicaltrials |
Data updated 4 days agoSource updated Sep 25, 2026source: clinicaltrials